Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-29T02:29:48.900Z Has data issue: false hasContentIssue false

A Controlled Trial of Cosaldon in Arteriosclerotic Dementia

Published online by Cambridge University Press:  29 January 2018

A. J. Cooper*
Affiliation:
Barrow Hospital, Barrow Gurney, near Bristol

Extract

Cosaldon has been fairly widely used on the Continent in the treatment of dementia and toxic confusional states. Meyer (1957), Leube (1959), Sperling (1960), Schmidt (1960), and Donati (1960) consider the drug to be of particular value in the treatment of arteriosclerotic dementia, and stress that the earlier the treatment is commenced the more favourable is the response.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1964 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bjurwill, B. (1963). “The effect of Cosaldon in elderly patients with cerebral sclerosis on the ability to orientate, memorize and think”, Swedish Med. J. Dnr., 3, 682.Google Scholar
Donati, A. (1960). “The treatment of cerebral sclerosis”, Praxis, 49, 2, 3739.Google Scholar
Florey, H. W. (1925). “Microscopical observations on the circulation of the blood in the cerebral cortex”, Brain, 48, 4364.Google Scholar
Leube, H. (1959). “Contribution to the therapy of cerebral sclerosis”, Arzt. Praxis, 12, 388390.Google Scholar
Meyer, J. (1957). Med. Klinik, 52, 24, 10731074.Google Scholar
Pickering, G. W. (1951). “Vascular spasm”, Lancet, ii, 845850.Google Scholar
Raven, J. C. (1947). “Guide to using Progressive Matrices”, Sets A, AB, B. London: Lewis.Google Scholar
Schmidt, B. (1960). “The treatment of cerebral sclerosis”, Med. Welt., 22.Google Scholar
Sperling, R. (1960). Med Klinik, 55, 845.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.